SPY315.49-0.69 -0.22%
DIA259.35-1.37 -0.53%
IXIC10,539.37+46.87 0.45%

PiperJaffray Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $7

PiperJaffray maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Neutral and raises the price target from $6 to $7.

Benzinga · -

PiperJaffray maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Neutral and raises the price target from $6 to $7.